Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactulose for organ dysfunction in critically ill patients
NCT01607060Phase 3Completed
- Sponsor
- Federal University of São Paulo
- Start
- Sep 2008
- Primary completion
- Apr 2012
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lactulose in constipation (2 arms), sponsored by Federal University of São Paulo. Primary endpoint: Change in Sequential Organ Failure Assessment score at 14 days. Started Sep 2008; status: completed.
02
Drugs
lactulose
03
Conditions
constipation
Beyond the preview
Go deeper on NCT01607060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01607060.